Watch COCHW. Know when insiders buy.
One email the day a filing lands. Free.
COCHW
Envoy Medical, Inc.
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $207K −6.8%NET INCOME −$23.4MNET CASH —52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $51K | −34.6% | -445.1% | −$5.6M | −$6M | — | -0.07 | −$5.5M | — | — | Aug 10 |
| Q1 2026 · Mar 31 | $39K | −15.2% | -702.6% | −$6M | −$4.4M | — | -0.08 | −$6.1M | — | — | Aug 10 |
| Q4 2025 · Dec 31derived | $75K | +78.6% | -181.3% | −$6.4M | −$6.6M | — | -0.26 | −$5.7M | $172K | −$5.9M | Mar 23 |
| Q3 2025 · Sep 30 | $42K | −25.0% | -383.3% | −$5.7M | −$6.5M | — | -0.35 | −$4.3M | $0 | −$4.3M | Nov 10 |
| Q2 2025 · Jun 30 | $78K | +14.7% | -200.0% | −$5.1M | −$5.7M | — | -0.32 | −$4.5M | $1K | −$4.5M | Aug 10 |
| Q1 2025 · Mar 31 | $46K | −22.0% | -391.3% | −$5.1M | −$5M | — | -0.29 | −$3.7M | $6K | −$3.7M | Aug 10 |
| Q4 2024 · Dec 31derived | $42K | −55.8% | -273.8% | −$4.5M | −$4.6M | — | -0.40 | −$5.1M | −$534K | −$4.6M | Mar 23 |
| Q3 2024 · Sep 30 | $56K | −30.0% | -233.9% | −$5M | −$6M | −481.3% | -0.39 | −$2.6M | $1.2M | −$3.8M | Nov 10 |
| Q2 2024 · Jun 30 | $68K | — | -260.3% | −$4.9M | −$3.9M | — | -0.29 | −$4.6M | $248K | −$4.9M | Nov 10 |
| Q1 2024 · Mar 31 | $59K | — | -159.3% | −$4.9M | −$6.3M | — | -0.41 | −$5.6M | $109K | −$5.7M | Nov 10 |
| Q4 2023 · Dec 31derived | $95K | — | -146.3% | −$6.7M | −$4.9M | — | -0.08 | −$11.1M | $21K | −$11.2M | Mar 31 |
| Q3 2023 · Sep 30 | $80K | — | -136.3% | −$3.4M | $1.6M | — | 0.13 | $1.1M | $62K | $1M | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $241K | -262.7% | −$22.3M | −$23.8M | -9857.3% | -1.23 | −$18.2M | $179K | −$18.4M | — | $1.8M |
| FY2024 · to Dec 31 | $225K | -229.8% | −$19.3M | −$20.8M | -9242.2% | -1.49 | −$17.9M | $980K | −$18.9M | — | $2.4M |
| FY2023 · to Dec 31 | $316K | -149.7% | −$18.4M | −$29.9M | -9469.0% | -2.54 | −$17.1M | $153K | −$17.2M | — | — |
| FY2022 · to Dec 31 | $237K | -110.1% | −$8.7M | −$15.9M | -6718.6% | -1.57 | −$8.8M | $218K | −$9M | — | — |
| FY2021 · to Dec 31 | — | — | −$5.2M | −$252K | — | — | −$3.2M | — | — | — | — |
Every number comes from Envoy Medical, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.